Form 4 Filing for BIO-TECHNE Corp

This filing details transactions made by Kim Kelderman, CEO of BIO-TECHNE Corp (TECH), on April 22, 2026. Kelderman acquired 11,344 shares of Common Stock at a price of $0.00, increasing their post-transaction holdings to 64,421 shares. Concurrently, Kelderman disposed of 1,363 shares of Common Stock at a price of $58.58 per share, resulting in post-transaction holdings of 63,058 shares. The filing also reports on various derivative transactions, including the acquisition and disposal of stock options and restricted stock units with different vesting schedules and exercise prices. Notably, Kelderman holds a significant number of stock options and restricted stock units set to vest over the next several years, with exercise prices ranging from $47.60 to $120.46.